BRAIN METASTASES OF GERM CELL TUMORS. THE RUSSIAN CANCER RESEARCH CENTER'S EXPERIENCE
- Authors: Tryakin A.A.1, Fedyanin M.Y.1, Bulanov A.A.1, Bekyashev A.K.1, Aleshin V.A.1, Mikhina Z.P.1, Matveev V.B.1, Zakharova T.I.1, Garin A.M.1, Tyulyandin S.A.1
-
Affiliations:
- N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
- Issue: Vol 9, No 4 (2013)
- Pages: 59-65
- Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. TESTICULAR CANCER
- Published: 30.12.2013
- URL: https://oncourology.abvpress.ru/oncur/article/view/150
- DOI: https://doi.org/10.17650/1726-9776-2013-9-4-59-65
- ID: 150
Cite item
Full Text
Abstract
This paper analyzes the experience in treating 20 patients with nonseminomatous germ cell tumors metastasizing to the brain. It presents brain metastasis-associated factors: multiple lung metastases; IGCCCG poor prognosis; and a baseline human chorionic gonadotropin level of > 50000 mIU/ml. The authors have identified a group to be screened for brain metastasis, which includes patients with intermediate/poor prognosis and multiple lung metastases. Long-term survival was achieved in 45 % of patients with baseline brain damage and in 22 % of those with metastases revealed after first-line chemotherapy. The positive prognostic factors associated with long-term survival were a single brain lesion, no neurological symptoms, and achievement of clinical complete personse in the brain.
About the authors
A. A. Tryakin
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Author for correspondence.
Email: atryakin@mail.ru
Department of Clinical Pharmacology and Chemotherapy
Russian FederationM. Yu. Fedyanin
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: atryakin@mail.ru
Department of Clinical Pharmacology and Chemotherapy
Russian FederationA. A. Bulanov
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: atryakin@mail.ru
Department of Clinical Pharmacology and Chemotherapy
Russian FederationA. Kh. Bekyashev
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: atryakin@mail.ru
Department of Neurosurgery
Russian FederationV. A. Aleshin
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: atryakin@mail.ru
Department of Neurosurgery
Russian FederationZ. P. Mikhina
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: atryakin@mail.ru
Department of Radiotherapy
Russian FederationV. B. Matveev
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: atryakin@mail.ru
Department of Urology
Russian FederationT. I. Zakharova
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: atryakin@mail.ru
Department of Pathomorphology
Russian FederationA. M. Garin
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: atryakin@mail.ru
Department of Clinical Pharmacology and Chemotherapy
Russian FederationS. A. Tyulyandin
N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: atryakin@mail.ru
Department of Clinical Pharmacology and Chemotherapy
Russian FederationReferences
Supplementary files

